INTRODUCTION
The Hippo signaling pathway was initially discovered in Drosophila as a potent mechanism that restricts organ size by impinging on cell growth, proliferation, and apoptosis. At the core of the Hippo signaling pathway is a kinase cascade composed of four tumor suppressor proteins, including the Ste20-like kinase Hippo (Hpo) (Wu et al., 2003; Udan et al., 2003; Harvey et al., 2003; Pantalacci et al., 2003; Jia et al., 2003) and its regulatory protein Salvador (Sav) (Tapon et al., 2002; Kango-Singh et al., 2002) , the NDR family kinase Warts (Wts) (Justice et al., 1995; Xu et al., 1995) , and its regulatory protein Mats (Lai et al., 2005) . The Hpo-Sav complex phosphorylates and activates the Wts-Mats complex (Wu et al., 2003; Wei et al., 2007) , which in turn phosphorylates and inactivates the oncoprotein Yki (Huang et al., 2005) by excluding the latter from the nucleus (Dong et al., 2007; Oh and Irvine, 2008) , where it normally functions as a coactivator for the TEAD/TEF family transcription factor Scalloped (Sd) (Wu et al., 2008; Zhang et al., 2008; Goulev et al., 2008) . Inactivation of the Hippo pathway tumor suppressors or overexpression of the Yki oncoprotein results in tissue overgrowth, characterized by excessive cell proliferation and diminished apoptosis. The Hippo pathway components are highly conserved from Drosophila to mammals, and mammalian homologs of Hpo (Mst1/2), Sav (WW45), Wts (Lats1/2), and Yki (YAP) constitute an analogous kinase cascade (Dong et al., 2007; Zhao et al., 2007; Praskova et al., 2008) . The importance of Hippo signaling in mammalian growth control is supported by reports that YAP is amplified in certain tumors and can transform immortalized mammary epithelial cells in vitro (Zender et al., 2006; Overholtzer et al., 2006) and that transgenic overexpression of YAP, or loss of Mst1/2, leads to massive hepatomegaly and rapid progression to hepatocellular carcinoma (HCC) (Dong et al., 2007; Camargo et al., 2007; Zhou et al., 2009; Lu et al., 2010; Song et al., 2010) . However, whether YAP is normally required for liver development or homeostasis has not been established.
Compared with the core kinase cascade leading from Hpo to Yki phosphorylation, proteins acting upstream of the Hippo kinase cascade are less well defined. Earlier studies in Drosophila have implicated the apical membrane-associated FERM-domain proteins Merlin (Mer) and Expanded (Ex) as pathway components upstream of Hpo Hamaratoglu et al., 2006; Pellock et al., 2007; Tyler and Baker, 2007) , although how Mer and Ex regulate Hpo activity was not established. Most recently, the WW and C2 domain-containing protein Kibra was identified as another apical membrane-associated tumor suppressor protein that functions together with Mer and Ex Baumgartner et al., 2010; Genevet et al., 2010) . Moreover, it was shown that these apical tumor suppressor proteins regulate the Hippo kinase cascade via direct binding to the Hpo-Sav complex . Recent studies further implicated the apical transmembrane protein Crumbs (Crb) as a cell surface protein that regulates Hippo signaling (Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010) by binding directly to Ex (Ling et al., 2010) . Besides Kibra, Ex, Mer, and Crb, the atypical cadherin Fat (Ft) (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006; Cho et al., 2006) , the CK1 family kinase Disc overgrown (Dco) (Sopko et al., 2009; Feng and Irvine, 2009) , and the myosin-like protein Dachs (Mao et al., 2006) have also been proposed as modulators of the Hippo pathway, although it is unresolved as to whether these proteins function upstream of Hpo in a linear pathway (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006) , or act in parallel with the Hippo kinase cascade by influencing the protein levels of Wts .
Among the proteins that have been implicated as upstream regulators of the Hippo signaling pathway, Mer is of particular clinical relevance since mutations of the mammalian gene encoding Mer, also known as Nf2, underlie Neurofibromatosis 2, an autosomal dominant disorder characterized by the development of benign schwannomas and other Schwann cell-derived tumors associated with the nervous system (McClatchey and Giovannini, 2005; Okada et al., 2007) . While the recent studies in Drosophila linking Mer to Hippo signaling suggest a potential mechanism by which Mer/NF2 may function as a tumor suppressor in mammals, it remains to be established whether Mer/NF2 regulates Hippo signaling in the context of normal mammalian physiology, and, furthermore, to what extent the supposed Mer/NF2-Hippo connection can account for Mer/NF2 0 s tumor suppressor function. The latter point is especially relevant given that besides the Hippo pathway, Mer/NF2 has been linked to a wide spectrum of effector pathways such as Ras, Rac, STAT, or PI3K signaling, as well as contact inhibition mediated by cell surface receptors or adherens junctions, and endocytosis/degradation of various membrane proteins (McClatchey and Giovannini, 2005; Okada et al., 2007) . Most recently, it was suggested that Mer/NF2 suppresses tumorigenesis in mammalian cells by translocating to the nucleus to inhibit a specific E3 ubiquitin ligase . Notably, the contributions of these effector pathways to Mer/NF2-mediated tumorigenesis have not been defined under physiological conditions such as within intact mammalian tissues and organs.
In this study, we use mouse genetics to dissect the physiological role of the Hippo signaling pathway, focusing on a single mammalian organ, the mouse liver. We found that loss of Yap in the liver led to not only defects in hepatocyte survival, as one would predict on the base of YAP's ability to induce hepatocyte proliferation and HCC formation, but also a profound defect in biliary epithelial cell development, suggesting that the Hippo-YAP pathway is normally required in these two major liver cell types. Interestingly, loss of Nf2 resulted in hyperplasia of both cell types evidenced by the formation of HCC and bile duct hamartoma, suggesting that NF2 and YAP function antagonistically to each other in the context of mammalian Hippo signaling. Strikingly, the Nf2-deficient liver phenotypes, as well as cataract formation caused by Nf2 deficiency in the lens epithelium, were largely suppressed by heterozygous deletion of the Yap gene, suggesting that YAP is a major effector of NF2 in growth regulation. Our studies link NF2 to mammalian Hippo signaling and implicate YAP as a potential drug target for the therapeutic intervention of Neurofibromatosis 2. (Xu et al., 2006; Geisler et al., 2008) . Successful deletion of Yap and Nf2 in the liver was confirmed by PCR genotyping ( Figure S1C ) and western blotting ( Figure 6A ). Quantitative RT-PCR showed that the Yap mRNA expression level in the liver of embryonic day 18.5 (E18.5) Yap mutant embryos was $30% of that in wild-type littermates. The expression level further decreased to 20% in 2-week-old mutant mice and 5% in 8-week-old mutant mice ( Figure S1D ).
RESULTS

Generation of Mice Lacking
Impaired Liver Function in Yap-Deficient Livers
Alb-Cre;Yap flox/flox mice were born with the expected Mendelian ratio and no overt abnormalities. However, examination of aged mutant mice revealed enlarged, pale livers ( Figure 1A) , and a moderate increase in liver/body weight ratio ( Figure 1B ). Histological analysis showed that the increased liver size resulted from macrovesicular steatosis ( Figure 1C ) and progressive fibrosis ( Figure 1D ). While no difference was seen between the mutant and control livers at 8 weeks of age, abnormal deposition of collagen was observed radiating from portal tracts in mutant livers at 20 weeks of age, indicating early periportal fibrosis.
In mutant mice at 30 weeks of age, progressive fibrosis was evident as bridges of fibrosis that connected individual portal tracts and entrapped islands of hepatocytes, indicating a more advanced fibrosis with cirrhosis. Consistent with impaired liver function, elevated serum bilirubin levels and alanine aminotransferase (ALT) levels were detected in the mutant mice, which indicated an abnormal biliary system and hepatocellular injury, respectively ( Figure 1E ).
YAP Is Required for Bile Duct Development
To investigate the etiology of the elevated serum bilirubin levels, we examined the biliary system of the Yap mutant mice. We stained the Yap-deficient livers with cytokeratin (CK), which is normally expressed in the biliary epithelial cells (BECs or cholangiocytes) of the liver (Geisler et al., 2008) . During the normal development of the intrahepatic bile ducts, hepatic progenitor cells adjacent to the portal veins undergo ductal commitment, forming a structure known as the ductal plate. Prior to birth, tubulogenesis occurs at discrete points along the ductal plates, giving rise to primitive ductal structures, while the remaining unincorporated BECs regress during the first 2 weeks of life (Lemaigre, 2003) . We noted that at E18.5, while control mice displayed typical ductal plate morphology with CK-positive BECs forming tubular and nontubular structures immediately adjacent to the portal vein, CK-positive BECs rarely formed such structures in Yap-deficient livers ( Figure 1F ). At this stage, loss of YAP did not affect the proliferation or apoptosis of BECs as revealed by Ki-67 and TUNEL staining (data not shown). From postnatal day 1 (P1) to postnatal day 14 (P14), tubular structures in control livers progressed into mature bile ducts that integrate into the portal mesenchyme, while CK-positive BECs in Yap-deficient livers regressed without forming mature bile ducts in the portal mesenchyme ( Figure 1F ). During the postnatal 1-5 month period, while control mice maintained a single mature bile duct within most portal tracts, Yap-deficient livers contained an increased number of CK-positive BECs forming irregularly shaped and variably sized structures circumferentially distributed in the periportal region ( Figure 1F ). These structures most likely represent a compensatory response to the absence of functional bile ducts, as observed previously in Notch2-deficient livers (Geisler et al., 2008) and typically seen in human chronic biliary disease (Nakanuma and Ohta, 1986) . However, these CK-positive cells did not persist, such that, in mutant mice older (E) Increased serum bilirubin and alanine aminotransferase (ALT) levels in Yap mutant mice. Control and mutant livers were analyzed at the indicated ages (values are means ± SEM): 1-2 months, n = 6; 3-5 months, n = 14; 6-12 months, n = 9. *p < 0.05, **p < 0.01, t test. (F) Impaired bile duct development in Yap mutant livers, as revealed by cytokeratin (CK) staining at the indicated ages. While CK-positive BECs in normal livers progressed from ductal plates to tubular structures around the portal veins from E18.5 to P7, the CK-positive BECs in Yap mutant livers were scattered around the portal veins and did not form typical tubular structures, leading to an absence of bile ducts at P14. An overabundance of CK-positive cells was present in 8-weekold Yap mutant livers, but these cells appeared disorganized and not incorporated into the portal mesenchyme, and did not persist in older mice (30-week-old). Scale bar = 50 mm. See Figure S1 for data supplemental to Figure 1 . than 30 weeks, there is a complete absence of any bile duct or bile duct-like structures leaving only fibrosis in the periportal region ( Figure 1F ). Taken together, these findings reveal a critical role for YAP in bile duct development.
YAP Is Required for Hepatocyte Survival
The increased serum ALT in Alb-Cre;Yap flox/flox mice suggests hepatocyte injury. Histological analysis of mutant livers revealed multiple areas of injured hepatocytes at the age of 1-2 months ( Figure 2A ). Hepatocytes in these injured areas were positive for cleaved Caspase-3 staining ( Figure 2B ), indicating that they were undergoing apoptosis. Although the visible apoptotic areas were mainly present in the mice at 1-2 months old, TUNEL staining showed increased numbers of apoptotic cells in Yap mutant livers at all ages examined ( Figure 2C ), suggesting that YAP is required for hepatocyte survival. Concomitant with increased hepatocyte death, Yap-deficient livers showed increased hepatocyte proliferation, as evidenced by increased mitotic figures ( Figure 2D ), Ki-67 staining ( Figure 2E ), and BrdU labeling (data not shown). Thus, there appeared to be increased turnover of hepatocytes in Yap-deficient livers, with increased hepatocyte death accompanied with increased proliferation. The increased hepatocyte turnover that was observed in the Yap mutant mice could reflect either a requirement for YAP in hepatocytes or a secondary response to the biliary defects in the Yap-deficient livers. To distinguish these two possibilities, we isolated and cultured primary hepatocytes in vitro. Compared with wild-type hepatocytes, Yap-deficient hepatocytes showed significantly decreased viability ( Figure 2F ) due to increased apoptosis in vitro ( Figure S2 ). Thus, inasmuch as overexpression of YAP in hepatocytes confers resistance to apoptosis (Dong et al., 2007; Camargo et al., 2007) , loss of YAP results in poor survival of the hepatocytes.
Loss of NF2 Leads to Hepatocyte and Biliary Epithelium Overproliferation
Heterozygous Nf2 knockout mice have been reported to develop a variety of tumors including hepatocellular carcinoma (9% incidence) (McClatchey et al., 1997) , but the specific function of NF2 in liver growth has not been investigated in detail. To this end, we generated Alb-Cre;Nf2 flox2/flox2 mice. Strikingly, the Alb-Cre; Nf2 flox2/flox2 mice developed widespread bile duct hamartomas, which appeared microscopically as collections of irregularly shaped duct-like structures surrounded by stroma and which were comprised of BECs without cellular atypia (Figures 3B and 3C) . Cytokeratin staining confirmed that the proliferating cells were of biliary cell origin ( Figure 3C ). As is typical of bile duct hamartomas, they first appeared at the surface of the liver and were observed in all mutant livers at 1 month of age ( Figure S4 ). These hamartomas continued to expand in adult life and extend from the hepatic capsule to the deep liver parenchyma, eventually dividing the liver into islands of hepatocytes ( Figures 3B and 3C ). In addition to bile duct hamartoma, hepatocellular carcinomas (HCC) developed in 100% of the mutant mice at 1 year of age ( Figures 3A and 3D ). The extensive proliferation of bile ducts and hepatocytes was so severe that the mutant livers represented $25% of the body weight at 1 year of age ( Figure 3F ). Figures 3E and 3G ). In agreement with the histological analysis, Nf2 mutant livers showed increased mRNA levels of osteopontin (OPN) and EpCAM, two BEC-enriched markers (Zong et al., 2009) , while Yap or Nf2 Yap livers showed a similar decrease of these BEC markers ( Figure 3H ). At 1 year of age, while Nf2 mutant livers showed widespread bile duct hamartomas, hamartomas were not detected in Nf2 Yap double mutant livers (Figures 3A-3C) . Third, while 100% of Nf2 mutant mice developed extensive HCC by 1 year of age, neither Yap nor Nf2 Yap mutant mice developed HCC at appreciable frequencies ( Figure 3D) . Last, the suppression of Nf2 mutant phenotype by loss of Yap is specific, since Yap deficiency did not suppress liver overgrowth and tumorigenesis induced by the expression of an oncogenic Kras mutant (G12D) (Tuveson et al., 2004) (Figures S3A-S3C) . Thus, Yap is genetically epistatic to Nf2 in liver growth.
In the course of analyzing the genetic interactions between Nf2 and Yap, we noted that even heterozygous deletion of Yap, which normally has no phenotypic consequences in an otherwise wild-type genetic background, caused significant suppression of the Nf2 mutant phenotype. Figures 4F and 4G) .
Thus, the suppression of Nf2-deficient phenotypes by Yap heterozygosity is not due to the removal of excess cells generated upon loss of Nf2, but rather indicative of a direct role for YAP in NF2-mediated signaling.
Yap Heterozygosity Suppresses Cataracts Induced By Loss of Nf2
The striking suppression of Nf2 mutant liver phenotypes by heterozygosity of Yap prompted us to examine whether such dosage-sensitive interaction is a general feature of NF2-YAP signaling. For this purpose, we examined the functional relationship between NF2 and YAP in the lens, wherein nearly all neurofibromatosis 2 patients are known to exhibit ocular defects such as presenile cataracts, which serve as one of the diagnostic criteria for this disease (Bouzas et al., 1993) . To model Neurofibromatosis 2-associated lens defects in mice, we conditionally deleted Nf2 using Nestin-Cre (Nes-Cre), which has been used for gene inactivation in the lens epithelium as early as E11.5 (Cang et al., 2006; Calera et al., 2006 ) (data not shown). Consistent with clinical findings, we found that loss of NF2 in the lens epithelium led to the formation of different types of cataracts characterized by the disorganization of lens epithelium in the anterior region of the lens (compare Figures 5D and 5E ), as well as accumulation of ectopic cells in the equator (compare Figures 5G and 5H ) and posterior (compare Figures 5J and 5K ) of the lens. Interestingly, all these defects were significantly suppressed by Yap heterozygosity (Figures 5F, 5I , and 5L). Together with our findings in the livers, these results support a general epistatic relationship between Yap and Nf2 in mammalian tissue growth.
NF2 Is Required for Hippo Signaling and Physically Associates with Canonical Pathway Components
To further corroborate a functional relationship between NF2 and YAP, we examined YAP S112 (corresponding to S127 of human YAP) phosphorylation, a specific Hippo signaling readout, in Nf2-deficient livers. Nf2-deficient livers showed reduced YAP S112 phosphorylation ( Figure 6A ). Consistent with this finding, Nf2-deficient livers showed increased nuclear YAP and elevated YAP protein levels, which was seen most prominently in the periportal areas ( Figure 6B ). Furthermore, Nf2-deficient livers displayed reduced Lats1/2 activity, as revealed by a phosphospecific antibody against its hydrophobic motif ( Figure 6A ). The reduction of YAP and Lats1/2 phosphorylation in Nf2-deficient livers was not merely a nonspecific consequence of cell overproliferation, as their phosphorylation levels were not reduced in liver overgrowth driven by oncogenic Kras G12D ( Figure S3D ). Conversely, Kras G12D , but not loss of NF2, led to activation of MAP kinase (Erk1/2) ( Figure 6A ; Figure S3D ). Taken together, these results demonstrate that endogenous NF2 is normally required for Hippo signaling in liver development and physiology. A recent study in Drosophila showed that Mer/NF2 can directly associate with Kibra, a newly identified tumor suppressor of the Hippo pathway, and Sav, a component of the Hpo-Sav kinase complex . To test whether such protein-protein interactions are conserved in their mammalian counterparts, we conducted coimmunoprecipitation assays to examine physical interactions between these mammalian proteins. Consistent with the findings in Drosophila, we found that epitope-tagged human KIBRA protein immunoprecipitated endogenous NF2 ( Figure 6C ), and endogenous NF2 and WW45 (the mammalian Sav homolog) coimmunoprecipitated with each other ( Figure 6D ).
The NF2-KIBRA interaction described here is consistent with our previous findings that coexpression of mammalian NF2 and KIBRA resulted in synergistic activation of Lats1/2 hydrophobic motif phosphorylation in HEK293 cells  see also Figure 6E ). To probe the functional significance of the observed NF2-WW45 interactions, we took advantage of the renal cancer cell line ACHN, which is known to have deleted WW45 (Tapon et al., 2002) . While coexpression of NF2 and KIBRA stimulated Lats2 hydrophobic motif phosphorylation in HEK293 cells (Figure 6E ), which are known to express WW45 (Dong et al., 2007) , NF2-KIBRA expression failed to stimulate Lats2 phosphorylation in the WW45-deficient ACHN cells (Figure 6E) . Importantly, reintroducing WW45 in ACHN cells rescued the ability of NF2-KIBRA to stimulate Lats2 phosphorylation, even though expression of WW45 by itself had no effect on Lats2 phosphorylation in either cell types ( Figure 6E) . Thus, at least in this cell culture context, WW45 is a critical mediator of NF2 input into Hippo signaling.
DISCUSSION
YAP Is Required for Liver Homeostasis
First discovered in Drosophila, the Hippo signaling pathway has recently emerged as a conserved mechanism that regulates tissue homeostasis in metazoans. In Drosophila and mammals, the Hippo pathway regulates growth by phosphorylating and inactivating the conserved transcriptional coactivator Yki (Drosophila) or its mammalian counterpart YAP. Consistent with its pivotal position in Hippo signaling, it was shown in Drosophila that gain-of-function of Yki, as exemplified by Yki overexpression or inactivation of tumor suppressors upstream of Yki, results in tissue overgrowth, whereas loss-of-function of Yki results in poor cell survival and tissue atrophy (Huang et al., 2005) . Interestingly, the evidence so far implicating Hippo signaling in mammalian tissue homeostasis are largely based on YAP gain-of-function contexts, wherein gene amplification (Zender et of Mst1/2 (Zhou et al., 2009; Lu et al., 2010; Song et al., 2010) , all lead to tissue overgrowth or cell transformation. Whether YAP is normally required for mammalian tissue development or homeostasis has not been examined.
Using a conditional mouse knockout model, we investigated the function of YAP in mouse livers. We found that loss of YAP in the liver not only results in defects in hepatocyte survival, but also leads to a profound defect in bile duct development. While primitive ductal plates can form in the vicinity of portal veins in Alb-Cre;Yap flox/flox livers, they never undergo dilation and progression into tubular bile ducts, thus resulting in bile duct paucity by 2 weeks of age. Despite the compensatory proliferation of periportal BECs, no bile ducts within or surrounding the portal tracts can persist in Yap-deficient livers older than 30 weeks of age. Thus, YAP is required for normal bile duct development. We note that the paucity of intrahepatic bile ducts in Yap-deficient livers resembles that observed in Alagille syndrome, a human disease caused by defective Notch signaling, as well as various mouse models with defective Notch signaling in the liver (Geisler et al., 2008) . However, defective Notch signaling is unlikely to account for the Yap mutant phenotype, since we observed no changes in the expression levels of various Notch pathway components ( Figure 3H) . Instead, the reciprocal bile duct defects in Yap-and Nf2-deficient livers implicate Hippo signaling as a pathway that regulates bile duct development independent of Notch.
A Functional Link between Merlin/NF2 and Hippo Signaling in Mammals
Since its initial discovery as a human disease gene underlying Neurofibromatosis 2, the Merlin/NF2 tumor suppressor has been the subject of intense investigation. While studies in mammalian cell cultures have linked a number of effector pathways to NF2 (McClatchey and Giovannini, 2005; Okada et al., 2007; Li et al., 2010) , the relative contribution of these effector pathways to NF2 function in intact tissues has not been defined. In this study, we provide multiple lines of evidence implicating a functional link between NF2 and the Hippo signaling pathway. First, inactivation of NF2 results in hyperplasia of hepatocytes and BECs accompanied by the formation of HCC and bile duct hamartoma, whereas inactivation of YAP results in the loss of both cell types, suggesting that NF2 and YAP act antagonistically to regulate tissue homeostasis in vivo. Second, loss of NF2 in vivo results in a decrease of YAP and Lats1/2 phosphorylation, as one would predict if NF2 functions as an upstream regulator of Hippo signaling in mammals. Third, in mammalian cell culture, NF2 physically associates with KIBRA and WW45, two known components of the Hippo pathway, and can stimulate Hippo signaling in a WW45-dependent manner. Last and foremost, the loss-of-Nf2 phenotype, both in the liver and in the lens, is largely suppressed by heterozygous deletion of Yap. This observation strongly implicates YAP as a major effector downstream from the NF2 tumor suppressor in mammalian growth control. To our knowledge, genetic interactions of such nature have not been reported for any other purported effector pathways downstream from NF2. That Yap heterozygosity, which is inconsequential in an Nf2+ genetic background, protects Nf2-deficient cells from tumor development further suggests that YAP may represent a potential drug target for the development of therapeutics against Neurofibromatosis 2, for which no effective treatments are available at present (Evans et al., 2009) . Recent studies in Drosophila showed that Mer/NF2 functions together with two other apical membrane-localized proteins Ex and Kibra to regulate the Hpo-Sav kinase complex . Our current study, together with the functional conservation of Mer/NF2 activity between Drosophila and mammals (LaJeunesse et al., 1998) , suggests that this aspect of Hippo signaling is likely conserved in mammals. How these apical proteins are regulated in either Drosophila or mammals remains an important and unanswered question that will likely be the focus of future investigation.
EXPERIMENTAL PROCEDURES
Generation of Yap Conditional Knock-Out Mice A targeting vector containing the first two exons of the Yap gene was generated by recombineering as described previously (Liu et al., 2003) . Transformed ES colonies were screened by long-template PCR with the following primer sets: P5F ( ACTGTCAATTAATGGGCTT-3 0 , P3: 5 0 -CAGTCTGTAACAACCAGTCAGGGAT AC-3 0 ) that generated a 498 bp band from the wild-type allele, a 597 bp band from the floxed allele, and a 697 bp band from the knockout allele ( Figure S1C ). To achieve liver-specific gene deletion, Yap flox/flox mice were bred to Albumin-Cre transgenic mice (003574) from the Jackson Laboratory (Bar Harbor, ME). To avoid potential variation related to gender, all experiments were performed in male mice with paternal inheritance of Alb-Cre.
Hepatocyte Isolation and Culture
All animal experiments were carried out in accordance with NIH guidelines for the care and use of experimental animals. Hepatocytes were isolated by twostep collagenase perfusion of 10-to 12-week-old Yap mutant mice and the littermate controls (Kreamer et al., 1986) . Cells were plated at a density of 1 3 10 4 cells per well of a 96-well plate and grown in D-MEM/F-12 medium (Invitrogen) supplemented with 13 ITS (insulin-transferrin-sodium selenite, Sigma), 30 mg/ml proline, 1 mg/ml galactose, 7.5% NaHCO 3 , and 13 penicillin/streptomycin at 37 C with 5% CO 2 as described (Kreamer et al., 1986 ).
The number of live cells was determined by the CellTiter 96 Non-Radioactive Cell Proliferation Assay (Promega; G4000). The experiments were performed in triplicate and repeated independently in three pairs of animals.
Quantitative Real-Time PCR Total liver cellular RNA was extracted using the TRIzol reagent (Invitrogen). RNA was reverse-transcribed with random primers using the Affinitycript multiple temperature cDNA synthesis kit (Stratagene). Real-time quantitative PCR (Q-PCR) was performed using the Quantitect SYBR Green PCR kit (QIAGEN) on a StepOnePlus PCR System (Applied Biosystems). Q-PCR was done in triplicate, using histone H2A.Z as a housekeeping control. Relative differences in the expression of the candidate genes in control and mutant livers were determined using the 2 -DDCt method. The mouse primer sequences used are available on request.
Histological Analysis and Immunostaining
Paraffin-embedded liver tissue was cut into 5 mm sections, which were stained with hematoxylin-eosin for histologic examination or with Sirius Red to visualize fibrosis. For analysis of adult lens, mouse skulls were fixed and decalcified in Formical-4, and processed for paraffin embedding and sections. Immunohistochemical and immunofluorescent staining were performed according to the protocols provided by the manufacturers of the respective antibodies. The following primary antibodies were used: Ki-67 (DAKO; M7249, 1/25), wide spectrum screening cytokeratin (pan-CK) (DAKO; Z0622, 1/500), Yap (Sigma; WH0010413M1, 1/100), NF2 (Sigma; HPA003097, 1/150), and cleaved Caspase-3 (Asp175) (Cell Signaling; #9661, 1/100). The secondary antibodies used were: Envision anti-rabbit (DAKO; K4002), and rabbit anti-goat IgG HRP (Santa Cruz Biotechnology; SC-2768, 1/100). The DAB+ (DAKO; K3467) visualization system was used for immunohistochemical staining, and Cy3-or Alexa488-conjugated rabbit secondary antibody was used for immunofluorescent staining. TUNEL staining was performed with the DeadEnd colorimetric TUNEL system (Promega; G7130) or In Situ Cell Death Detection Kit (Roche) according to the manufacturers' instructions.
BEC and Bile Duct Quantification
To quantify the pan-CK + cells and bile ducts in the E18.5 embryo, we evaluated 10 randomly chosen 203 fields/section for each mouse. The numbers of pan-CK + cells and bile ducts were quantified by adding the respective numbers for each 203 field.
Protein Lysate and Western Blot Analysis
Cells or tissues were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 1% NP-40, 0.5% sodium-deoxycholate, 0.1% SDS, and 1 mM PMSF) with protease inhibitors (Roche). The proteins were separated on SDS-polyacrylamide gels and transferred onto PVDF membranes (Millipore). The blots were probed with antibodies against YAP (Cell Signaling; #4912), phospho-YAP (Ser127) (Cell Signaling; #4911), Lats1 (Cell Signaling; #3477), phospho-Lats1/2 , Erk1/2 (Cell Signaling; #4696), PhosphoErk1/2 (Thr202/Tyr204) (Cell Signaling; #4370), and NF2 (Sigma; HPA003097) and normalized by Actin (Millipore; MAB1501). Signals were detected and quantified by LI-COR Infrared Imaging system.
Mammalian Cell Culture and Immunoprecipitation HEK293 cells and ACHN cells were maintained in DMEM medium supplemented with 10% fetal bovine serum and antibiotics (Invitrogen). The T7-KIBRA, Myc-Lats2, Myc-WW45, and HA-NF2 expression plasmids were described previously . Immunoprecipitation was carried out using RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris [pH 8.0]) supplemented with 1 mM PMSF and protease inhibitors (Roche). Antibodies for western blot include phospho-Lats , Myc (Santa Cruz, Sc40 HRP), T7 (Novagen, #69522), NF2 (Sigma; HPA003097), and WW45 (Novus, H00060485-M02).
Serum ALT and Direct Bilirubin Measurements
Serum levels of alanine aminotransferase (ALT) and direct bilirubin were measured using commercially available kits (product nos. 68-D and 020-A, respectively) from Biotron Diagnostic Inc. (Hemet, CA) according to the manufacturer's protocol.
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